首页> 外文学位 >Detection and characterization of early-phase experimental radiation-induced heart disease
【24h】

Detection and characterization of early-phase experimental radiation-induced heart disease

机译:早期实验性放射源性心脏病的检测和表征

获取原文
获取原文并翻译 | 示例

摘要

Radiation-induced heart disease (RIHD) is a potentially severe side effect of thoracic radiotherapy for malignancies including Hodgkin's disease and breast, lung, or esophageal cancers. Due to its precarious location in the thoracic cavity, the heart can be irradiated unintentionally when administering radiotherapy for these tumors. As a result, many years after radiotherapy, end-stage manifestations of heart disease may present abruptly following 10 or more years of latency. Unfortunately, very little is known about mechanisms and early biomarkers during the early phase of human or experimental RIHD. We sought to characterize early RIHD in a rat model using local heart irradiation, and to evaluate dobutamine stress testing (DST) as an early diagnostic test to detect RIHD.;We reported earlier that the kallikrein-kinin system (KKS), and its best known constituent bradykinin, plays a primarily cardioprotective role by ameliorating inflammation in the irradiated heart at 3 months post-irradiation, but whether the KKS regulates the early inflammatory response to RIHD is largely unknown. To explore this possibility, we subcutaneously administered 0.5 mg/kg/day HOE-140, a bradykinin B2 receptor antagonist, to animals receiving 21 Gy or Sham-irradiation and examined molecular signaling at 1 month post-irradiation. Local heart irradiation caused increased phosphorylation of c-Jun, which was further enhanced by HOE-140 treatment in irradiated rats. This phosphorylation led to a functional consequence; nuclear translocation of c-Jun was increased in irradiated hearts, and further increased in animals treated with HOE-140. Macrophage infiltration was increased in irradiated animals treated with HOE-140, implying that B2 receptors inhibit macrophage infiltration in early-phase RIHD.;Cardiac stress tests are used widely in patients to predict the risk of major coronary events. However, despite the fact that patients subjected to thoracic irradiation are susceptible to cardiac ischemia, we lack an early diagnostic test to identify patients at risk for RIHD. Therefore, we explored whether cardiac stress testing using dobutamine, a ?1-adrenoreceptor agonist, could unmask electrocardiographic (ECG) abnormalities of the irradiated heart to provide an early diagnostic test to detect pending RIHD. We showed that T-wave amplitudes on ECGs of resting irradiated rats were elevated at 60 and 90 days post-irradiation. However, DST provoked T-wave elevation in irradiated rats as early as 10 days after 5 x 9 Gy irradiation and as early as 20 days after 5 x 6 Gy irradiation; at these time-points, resting T-wave amplitudes were not significantly different from Sham rats. DST-induced T-wave elevation in irradiated rats preceded functional changes (increased ejection fraction and fractional shortening) and histological changes (myocardial fibrosis), which occurred at 3 months post-irradiation. Because T-wave elevation can indicate myocardial ischemia, we investigated etiologies and indicators of ischemic injury and ECG alterations in the heart. Local heart irradiation caused release of troponin-I at 60 days post-irradiation; a time point associated with elevated T-waves at rest. Systemic hyperkalemia and hypercalcemia can cause T-wave elevation; however, both plasma potassium and calcium concentrations were not altered by irradiation or stress testing at 30 days post-irradiation. Endothelial function, as measured by endothelium-dependent vasodilator responses of isolated coronary septal arteries from irradiated hearts, also was unchanged at 1 month post-IR, which failed to implicate endothelial dysfunction as a contributor to T-wave elevation or myocardial ischemia.;Thus, early phase experimental RIHD in our rat model of this pathology is characterized by aberrant bradykinin signaling and ECG disturbances, which may be indicators of myocardial ischemia. DST may be a useful diagnostic tool to provoke T-wave elevation on ECG as an early predictor of latent RIHD.
机译:放射诱发性心脏病(RIHD)是胸腔放疗对霍奇金病和乳腺癌,肺癌或食道癌等恶性肿瘤的潜在严重副作用。由于其在胸腔中的位置不稳定,对这些肿瘤进行放射治疗时可能会无意中照射心脏。结果,放疗后很多年,潜伏期超过10年或更长时间,心脏病的晚期表现可能会突然出现。不幸的是,对于人类或实验性RIHD早期阶段的机制和早期生物标志物知之甚少。我们试图在使用局部心脏照射的大鼠模型中表征早期RIHD,并评估多巴酚丁胺应激测试(DST)作为检测RIHD的早期诊断测试。;我们之前报道过激肽释放酶激肽系统(KKS)及其最佳已知的缓激肽成分,通过减轻照射后3个月被照射心脏的炎症,起主要的心脏保护作用,但KKS是否调节RIHD的早期炎症反应尚不清楚。为了探索这种可能性,我们对接受21 Gy或Sham照射的动物皮下注射了0.5 mg / kg / day的缓激肽B2受体拮抗剂HOE-140,并在照射后1个月检查了分子信号传导。局部心脏照射导致c-Jun磷酸化增加,HOE-140处理可进一步增强c-Jun的磷酸化。这种磷酸化导致功能上的后果。 c-Jun的核转位在受辐照的心脏中增加,在用HOE-140处理的动物中进一步增加。在接受HOE-140治疗的受辐照动物中,巨噬细胞浸润增加,这表明B2受体抑制了早期RIHD中的巨噬细胞浸润。心脏压力测试已广泛用于患者中,以预测重大冠脉事件的风险。但是,尽管事实上接受胸腔照射的患者易患心脏缺血,但我们仍缺乏早期诊断测试来确定有RIHD风险的患者。因此,我们探讨了使用多巴酚丁胺(β1-肾上腺素能受体激动剂)进行心脏压力测试是否可以掩盖受辐照心脏的心电图(ECG)异常,从而提供早期诊断测试以检测未决的RIHD。我们显示,在辐照后60天和90天,静息辐照大鼠的ECG的T波振幅升高。但是,DST最早在5 x 9 Gy照射后10天和5 x 6 Gy照射后20天引起了被照射大鼠的T波升高。在这些时间点,静息T波振幅与Sham大鼠无明显差异。 DST诱导的辐照大鼠T波升高先于辐照后3个月发生功能改变(射血分数增加和分数缩短)和组织学改变(心肌纤维化)。由于T波升高可以指示心肌缺血,因此我们研究了心脏缺血性损伤和ECG改变的病因和指标。心脏局部照射在照射后60天导致肌钙蛋白I释放;与静止T波升高相关的时间点。系统性高钾血症和高钙血症可引起T波升高;然而,在辐照后30天,通过辐照或压力测试并没有改变血浆钾和钙的浓度。红外线照射后1个月时,内皮功能(通过用辐照后的心脏分离出的冠状动脉间隔血管的内皮依赖性血管舒张反应测得)也没有变化,这未能暗示内皮功能障碍是T波升高或心肌缺血的原因。 ,我们这种病理模型的早期实验性RIHD的特征在于缓激肽信号转导和ECG异常,这可能是心肌缺血的指标。 DST可能是一种有用的诊断工具,可引起ECG的T波升高,作为潜在RIHD的早期预测指标。

著录项

  • 作者

    Lieblong, Benjamin J.;

  • 作者单位

    University of Arkansas for Medical Sciences.;

  • 授予单位 University of Arkansas for Medical Sciences.;
  • 学科 Pharmacology.
  • 学位 Ph.D.
  • 年度 2016
  • 页码 185 p.
  • 总页数 185
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号